EUVIMEDEUVIMED entdecken
Editorial

Human neuroendocrine cells are potential targets for engineered neuron replacement therapy

Jacob Short iD, Susan Wray iD

Journal of Neuroendocrinology · 2026-11 · 38 (11)

DOI: 10.1111/jne.70310 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 13.11.2026. Verfasst von Jacob Short und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Neurons, Neuroendocrine Cells. Die Arbeit nennt 131 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review focuses on the potential for intervention in hormone disorders by replacing neuroendocrine cells with engineered cells that avoid amplifying dysfunctional brain–body feedback by independently sending healthy signals to the body. This paradigm presents opportunities to develop treatment strategies for common disorders often overlooked in favor of symptom reduction, particularly in women's health. Numerous neuroendocrine cells integrate signals from the hormone control centers of the brain and release their signals to the anterior pituitary via the hypophyseal portal system. Subsequent release of pituitary hormones carries the signals throughout the body. Hormones produced by peripheral organs form feedback loops, sending their signals to multiple brain circuits to be processed and delivered back to the hormone control centers. This brain–body feedback system maintains homeostasis, reproductive and metabolic function, and affects social behavior. Dysfunction of these feedback systems presents a unique target for neuron replacement therapy. Therapeutic potential is introduced by using neuroendocrine replacement cells, modified in vitro do to form synthetic gene circuits that will override the dysfunctional brain–body feedback in vivo and act as hormone regulators. Specific strategies for reversing disorders in the hormone systems are presented, which serve as alternatives to hormone therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuronsNeuroendocrine CellsHumansFeedback, PhysiologicalAnimals

Stichwörter der Autor:innen

brain–body feedbackcell‐based therapyhormone therapyneuroengineeringreproductive health

Autor:innen und Institutionen

  • National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Jacob Short, Susan Wray

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Short, J., & Wray, S. (2026). Human neuroendocrine cells are potential targets for engineered neuron replacement therapy. Journal of Neuroendocrinology, 38(11). https://doi.org/10.1111/jne.70310

Vancouver

Short J, Wray S. Human neuroendocrine cells are potential targets for engineered neuron replacement therapy. Journal of Neuroendocrinology. 2026;38(11). doi:10.1111/jne.70310

BibTeX
@article{Short2026,
  author = {Short, Jacob and Wray, Susan},
  title = {Human neuroendocrine cells are potential targets for engineered neuron replacement therapy},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  volume = {38},
  number = {11},
  doi = {10.1111/jne.70310}
}
Kostenlos starten →